Effect of Menstrugole on primary dysmenorrhea: a randomized clinical trial
Obstetrics & Gynecology Science
;
: 684-687, 2018.
Article
in English
| WPRIM
| ID: wpr-718352
ABSTRACT
OBJECTIVE:
Primary dysmenorrhea occurs in more than 50% of women of reproductive age. This survey evaluated the effects of Menstrugole on the alleviation of primary dysmenorrhea.METHODS:
This study was performed in western Iran between August 15 and December 15, 2017, in female students with primary dysmenorrhea. The students were randomly divided into 2 groups and received placebo or a Menstrugole capsule for 3 days in each of 2 menstrual cycles. The visual analog scale was used to assess pain severity. The χ2 test, one-way analysis of variance, and the paired t-test were used for statistical evaluation.RESULTS:
We compared the severity of pain between the 2 groups. There was a significant change in the mean pain score during the first (P < 0.001) and second months (P < 0.001) after the use of Menstrugole, compared with that in the placebo group.CONCLUSION:
Menstrugole decreased pain severity in female students, and can be considered by health care providers for treatment of primary dysmenorrhea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Health Personnel
/
Dysmenorrhea
/
Visual Analog Scale
/
Analgesics
/
Iran
/
Menstrual Cycle
Type of study:
Controlled clinical trial
Limits:
Adolescent
/
Female
/
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Obstetrics & Gynecology Science
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS